Bristol-Myers Squibb
BMY
#174
Rank
NZ$207.37 B
Marketcap
NZ$101.57
Share price
0.46%
Change (1 day)
10.07%
Change (1 year)

Bristol-Myers Squibb (BMY) - Net assets

Net assets on the balance sheet as of December 2025 : NZ$31.60 Billion

According to Bristol-Myers Squibb's latest financial reports the company has NZ$31.60 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bristol-Myers Squibb - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2025-12-31$NZ$31.95 B9.96%
2024-12-31$NZ$29.05 B-37.68%
2023-12-31$NZ$46.62 B-4.87%
2022-12-31$NZ$49.01 B-7.02%
2021-12-31$NZ$52.71 B0.4%
2020-12-31$NZ$52.50 B-31.61%
2019-12-31$NZ$76.76 B264.48%
2018-12-31$NZ$21.06 B26.26%
2017-12-31$NZ$16.68 B-29.32%
2016-12-31$NZ$23.59 B11.98%
2015-12-31$NZ$21.07 B10.21%
2014-12-31$NZ$19.12 B3.14%
2013-12-31$NZ$18.54 B11.84%
2012-12-31$NZ$16.57 B-18.46%
2011-12-31$NZ$20.33 B0.3%
2010-12-31$NZ$20.26 B-0.42%
2009-12-31$NZ$20.35 B-3.24%
2008-12-31$NZ$21.03 B52.57%
2007-12-31$NZ$13.78 B-2.77%
2006-12-31$NZ$14.18 B-13.52%
2005-12-31$NZ$16.39 B14.69%
2004-12-31$NZ$14.29 B-5.03%
2003-12-31$NZ$15.05 B-10.02%
2002-12-31$NZ$16.73 B-23.44%
2001-12-31$NZ$21.85 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
NZ$139.26 B 340.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$79.50 B 151.53%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$148.20 B 368.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$5.52 Billion-117.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$45.31 B 43.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.78 B-53.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$143.87 B 355.20%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$31.18 B-1.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$89.94 B 184.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$83.20 B 163.26%๐Ÿ‡ฌ๐Ÿ‡ง UK